Evidence map›Paper›PMID 38869636›Full record

ArticleJournal of robotic surgery2024

Cost analysis of new robotic competitors: a comparison of direct costs for initial hospital stay between Da Vinci and Hugo RAS for radical prostatectomy.

Maria Chiara Sighinolfi, Luigi Amerigo Messina, Matteo Stocco, Marcio Covas Moscovas, Paolo Pelliccia, Alessia Palma, Marta Rossini, Angela Gallo, Augusto Ramondo, Efrem Pozzi and 5 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of robotic surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Hugo™ RAS versus da VinciBMC surgery · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Medtronic's HugoJournal of robotic surgery · 2024
    Pooled it
  7. Pooled it
  8. Systematic Review and Clinical Outcomes of new Robotic Systems in Urology.International braz j urol : official journal of the Brazilian Society of Urology
    Pooled it
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Maria Chiara SighinolfiUrologic Unit, ASST Santi Paolo and Carlo, Milan, Italy. sighinolfic@gmail.com.
Luigi Amerigo MessinaBudgeting and Reporting's Office, ASST Santi Paolo and Carlo, Milan, Italy.
Matteo StoccoBudgeting and Reporting's Office, ASST Santi Paolo and Carlo, Milan, Italy.
Marcio Covas MoscovasAdventhealth, Global Robotic Institute, Celebration, FL, USA.
Paolo PellicciaBudgeting and Reporting's Office, ASST Santi Paolo and Carlo, Milan, Italy.
Alessia PalmaBudgeting and Reporting's Office, ASST Santi Paolo and Carlo, Milan, Italy.
Marta RossiniBudgeting and Reporting's Office, ASST Santi Paolo and Carlo, Milan, Italy.
Angela GalloBudgeting and Reporting's Office, ASST Santi Paolo and Carlo, Milan, Italy.
Augusto RamondoUrologic Unit, ASST Santi Paolo and Carlo, Milan, Italy.
Efrem PozziUrologic Unit, ASST Santi Paolo and Carlo, Milan, Italy.
Simone AssummaUrologic Unit, ASST Santi Paolo and Carlo, Milan, Italy.
Stefano TerzoniUrologic Unit, ASST Santi Paolo and Carlo, Milan, Italy.
Marco SandriAdventhealth, Global Robotic Institute, Celebration, FL, USA.
Vipul PatelAdventhealth, Global Robotic Institute, Celebration, FL, USA.
Bernardo RoccoUrologic Unit, ASST Santi Paolo and Carlo, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Robotic surgery with Da Vinci has revolutionized the treatment of several diseases, including prostate cancer; nevertheless, costs remain the major drawback. Recently, new robotic platforms entered the market aiming to reduce costs and improve the access to robotic surgery. The aim of the study is to compare direct cost for initial hospital stay of radical prostatectomy performed with two different robotic systems, the Da Vinci and the new Hugo RAS system. This is a projection study that applies cost of robotic surgery, derived from a local tender, to the clinical course of robotic radical prostatectomy (RALP) performed with Da Vinci and Hugo RAS. The study was performed in a public referral center for robotic surgery equipped with both systems. The cost of robotic surgery from a local tender were considered and included rent, annual maintenance, and a per-procedure fee covering the setup of four robotic instruments. Those costs were applied to patients who underwent RALP with both systems since November 2022. The primary endpoint is to evaluate direct costs of initial hospital stay for Da Vinci and Hugo RAS, by considering equipment costs (as derived from the tender), and costs of theater and of hospitalization. The direct per-procedure cost is €2,246.31 for a Da Vinci procedure and €1995 for a Hugo RALP. In the local setting, Hugo RAS provides 11% of cost saving for RALP. By applying this per-procedure cost to our clinical data, the expenditure for the entire index hospitalization is € 6.7755,1 for Da Vinci and € 6.637,15 for Hugo RALP. The new Hugo RAS system is willing to reduce direct expenditures of robotic surgery for RALP; furthermore, it provides similar peri-operative outcomes compared to the Da Vinci. However, other drivers of costs should be taken into account, such as the duration of OR use-that is more than just console time and may depend on the facility's background and organization. Further variations in direct costs of robotic systems are related to caseload, local agreements and negotiations. Thus, cost comparison of new robotic platform still remains an ongoing issue.

Indexed as

Costs and Cost AnalysisLength of StayProstatectomyProstatic NeoplasmsRobotic Surgical ProceduresHumansMaleCost analysisDirect costsEconomicsNew robotic systemsRobotic surgery

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.